Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Jan;37(1):44–49. doi: 10.1136/jmg.37.1.44

A search for evidence of somatic mutations in the NF1 gene

A John 1, M Ruggieri 1, R Ferner 1, M Upadhyaya 1
PMCID: PMC1734445  PMID: 10633134

Abstract

Neurofibromatosis type I (NF1) is an autosomal dominant disorder affecting 1 in 3000 people. The NF1 gene is located on chromosome 17q11.2, spans 350 kb of genomic DNA, and contains 60 exons. A major phenotypic feature of the disease is the widespread occurrence of benign dermal and plexiform neurofibromas. Genetic and biochemical data support the hypothesis that NF1 acts as a tumour suppressor gene. Molecular analysis of a number of NF1 specific tumours has shown the inactivation of both NF1 alleles during tumourigenesis, in accordance with Knudson's "two hit" hypothesis. We have studied 82 tumours from 45 NF1 patients. Two separate strategies were used in this study to search for the somatic changes involved in the formation of NF1 tumours. First, evidence of loss of heterozygosity (LOH) of the NF1 gene region was investigated, and, second, a screen for the presence of sequence alterations was conducted on a large panel of DNA derived from matched blood/tumour pairs. In this study, the largest of its kind to date, we found that 12% of the tumours (10/82) exhibited LOH; previous studies have detected LOH in 3-36% of the neurofibromas examined. In addition, an SSCP/HA mutation screen identified five novel NF1 germline and two somatic mutations. In a plexiform neurofibroma from an NF1 patient, mutations in both NF1 alleles have been characterised.


Keywords: neurofibromatosis; NF1 gene; somatic mutations

Full Text

The Full Text of this article is available as a PDF (197.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abernathy C. R., Rasmussen S. A., Stalker H. J., Zori R., Driscoll D. J., Williams C. A., Kousseff B. G., Wallace M. R. NF1 mutation analysis using a combined heteroduplex/SSCP approach. Hum Mutat. 1997;9(6):548–554. doi: 10.1002/(SICI)1098-1004(1997)9:6<548::AID-HUMU8>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]
  2. Abernathy C., Colman S. D., Wallace M. R. A PCR-based test for a polymorphism within the human NF1 gene. Clin Genet. 1994 Jun;45(6):313–313. doi: 10.1111/j.1399-0004.1994.tb04038.x. [DOI] [PubMed] [Google Scholar]
  3. Barker D., Wright E., Nguyen K., Cannon L., Fain P., Goldgar D., Bishop D. T., Carey J., Baty B., Kivlin J. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science. 1987 May 29;236(4805):1100–1102. doi: 10.1126/science.3107130. [DOI] [PubMed] [Google Scholar]
  4. Colman S. D., Williams C. A., Wallace M. R. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet. 1995 Sep;11(1):90–92. doi: 10.1038/ng0995-90. [DOI] [PubMed] [Google Scholar]
  5. Cowley G. S., Murthy A. E., Parry D. M., Schneider G., Korf B., Upadhyaya M., Harper P., MacCollin M., Bernards A., Gusella J. F. Genetic variation in the 3' untranslated region of the neurofibromatosis 1 gene: application to unequal allelic expression. Somat Cell Mol Genet. 1998 Mar;24(2):107–119. doi: 10.1023/b:scam.0000007113.28381.53. [DOI] [PubMed] [Google Scholar]
  6. Däschner K., Assum G., Eisenbarth I., Krone W., Hoffmeyer S., Wortmann S., Heymer B., Kehrer-Sawatzki H. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem Biophys Res Commun. 1997 May 19;234(2):346–350. doi: 10.1006/bbrc.1997.6645. [DOI] [PubMed] [Google Scholar]
  7. Fain P. R., Barker D. F., Goldgar D. E., Wright E., Nguyen K., Carey J., Johnson J., Kivlin J., Willard H., Mathew C. Genetic analysis of NF1: identification of close flanking markers on chromosome 17. Genomics. 1987 Dec;1(4):340–345. doi: 10.1016/0888-7543(87)90034-6. [DOI] [PubMed] [Google Scholar]
  8. Gonzalez-Zulueta M., Bender C. M., Yang A. S., Nguyen T., Beart R. W., Van Tornout J. M., Jones P. A. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995 Oct 15;55(20):4531–4535. [PubMed] [Google Scholar]
  9. Herman J. G., Latif F., Weng Y., Lerman M. I., Zbar B., Liu S., Samid D., Duan D. S., Gnarra J. R., Linehan W. M. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9700–9704. doi: 10.1073/pnas.91.21.9700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Herman J. G., Merlo A., Mao L., Lapidus R. G., Issa J. P., Davidson N. E., Sidransky D., Baylin S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995 Oct 15;55(20):4525–4530. [PubMed] [Google Scholar]
  11. Hoff M., Nakamura Y., Holm T., Ballard L., O'Connell P., Leppert M., Lathrop G. M., Lalouel J. M., White R. Isolation and mapping of a polymorphic DNA sequence pHHH202 on chromosome 17 [D17S33]. Nucleic Acids Res. 1988 Jan 25;16(2):781–781. doi: 10.1093/nar/16.2.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hoffmeyer S., Assum G. An RsaI polymorphism in the transcribed region of the neurofibromatosis (NF1)-gene. Hum Genet. 1994 Apr;93(4):481–482. doi: 10.1007/BF00201684. [DOI] [PubMed] [Google Scholar]
  13. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Legius E., Marchuk D. A., Collins F. S., Glover T. W. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet. 1993 Feb;3(2):122–126. doi: 10.1038/ng0293-122. [DOI] [PubMed] [Google Scholar]
  15. Li Y., O'Connell P., Breidenbach H. H., Cawthon R., Stevens J., Xu G., Neil S., Robertson M., White R., Viskochil D. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics. 1995 Jan 1;25(1):9–18. doi: 10.1016/0888-7543(95)80104-t. [DOI] [PubMed] [Google Scholar]
  16. Lázaro C., Gaona A., Estivill X. Two CA/GT repeat polymorphisms in intron 27 of the human neurofibromatosis (NF1) gene. Hum Genet. 1994 Mar;93(3):351–352. doi: 10.1007/BF00212039. [DOI] [PubMed] [Google Scholar]
  17. Lázaro C., Gaona A., Xu G., Weiss R., Estivill X. A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene. Hum Genet. 1993 Oct;92(4):429–430. doi: 10.1007/BF01247353. [DOI] [PubMed] [Google Scholar]
  18. Maynard J. H., Upadhyaya M. High-throughput screening for the detection of unknown mutations: improved productivity using heteroduplex analysis. Biotechniques. 1998 Oct;25(4):648–651. doi: 10.2144/98254dt02. [DOI] [PubMed] [Google Scholar]
  19. Maynard J., Krawczak M., Upadhyaya M. Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene. Hum Genet. 1997 May;99(5):674–676. doi: 10.1007/s004390050427. [DOI] [PubMed] [Google Scholar]
  20. Purandare S. M., Lanyon W. G., Connor J. M. Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. Hum Mol Genet. 1994 Jul;3(7):1109–1115. doi: 10.1093/hmg/3.7.1109. [DOI] [PubMed] [Google Scholar]
  21. Régnier V., Danglot G., Nguyen V. C., Bernheim A. A Tsp509I variant in exon 13 of the neurofibromatosis type 1 (NF1) gene allows the identification of both alleles at the mRNA level. Hum Genet. 1995 Jul;96(1):131–132. doi: 10.1007/BF00214202. [DOI] [PubMed] [Google Scholar]
  22. Sakai T., Toguchida J., Ohtani N., Yandell D. W., Rapaport J. M., Dryja T. P. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet. 1991 May;48(5):880–888. [PMC free article] [PubMed] [Google Scholar]
  23. Sawada S., Florell S., Purandare S. M., Ota M., Stephens K., Viskochil D. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet. 1996 Sep;14(1):110–112. doi: 10.1038/ng0996-110. [DOI] [PubMed] [Google Scholar]
  24. Seizinger B. R. NF1: a prevalent cause of tumorigenesis in human cancers? Nat Genet. 1993 Feb;3(2):97–99. doi: 10.1038/ng0293-97. [DOI] [PubMed] [Google Scholar]
  25. Seizinger B. R., Rouleau G. A., Ozelius L. J., Lane A. H., Faryniarz A. G., Chao M. V., Huson S., Korf B. R., Parry D. M., Pericak-Vance M. A. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell. 1987 Jun 5;49(5):589–594. doi: 10.1016/0092-8674(87)90534-4. [DOI] [PubMed] [Google Scholar]
  26. Serra E., Puig S., Otero D., Gaona A., Kruyer H., Ars E., Estivill X., Lázaro C. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet. 1997 Sep;61(3):512–519. doi: 10.1086/515504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shannon K. M., O'Connell P., Martin G. A., Paderanga D., Olson K., Dinndorf P., McCormick F. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med. 1994 Mar 3;330(9):597–601. doi: 10.1056/NEJM199403033300903. [DOI] [PubMed] [Google Scholar]
  28. Upadhyaya M., Ruggieri M., Maynard J., Osborn M., Hartog C., Mudd S., Penttinen M., Cordeiro I., Ponder M., Ponder B. A. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet. 1998 May;102(5):591–597. doi: 10.1007/s004390050746. [DOI] [PubMed] [Google Scholar]
  29. Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver M., Carey J. C., Copeland N. G., Jenkins N. A. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990 Jul 13;62(1):187–192. doi: 10.1016/0092-8674(90)90252-a. [DOI] [PubMed] [Google Scholar]
  30. Weber J. L., Kwitek A. E., May P. E., Wallace M. R., Collins F. S., Ledbetter D. H. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res. 1990 Aug 11;18(15):4640–4640. [PMC free article] [PubMed] [Google Scholar]
  31. Xu G. F., Nelson L., O'Connell P., White R. An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1). Nucleic Acids Res. 1991 Jul 11;19(13):3764–3764. doi: 10.1093/nar/19.13.3764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Xu G. F., O'Connell P., Viskochil D., Cawthon R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990 Aug 10;62(3):599–608. doi: 10.1016/0092-8674(90)90024-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES